Connect with us

Health

Glucosidase inhibitors are promising as new therapeutic agents for SARS-CoV-2 – Eminetra

In a new study posted on bioRxiv* Preprint server, US researchers found that two iminosugar glucosidase inhibitors suppress the replication of severe acute respiratory…

Published

on

Article feature image

In a new study posted on bioRxiv* Preprint server, US researchers found that two iminosugar glucosidase inhibitors suppress the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in tissue culture at least one-hundredth of the required concentration. It reports that it has the ability to do so because of its cytotoxic effects.
As the pandemic of coronavirus disease 2019 (COVID-19) progresses, there is an urgent need for new antiviral agents that are effective against SARS-CoV-2,…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending